Combining therapies for alcohol use and liver disease
Integrated therapies for alcohol use and ALD (ITAALD) Network – UTSW Clinical Center
This study is looking for better ways to help people with alcohol-related liver disease by combining treatments for both liver issues and alcohol use, so that patients can get the support they need without feeling judged.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11077507 on NIH RePORTER |
What this research studies
This research focuses on improving treatment for patients suffering from alcohol-associated liver disease (ALD), which currently has no FDA-approved therapies. It aims to integrate care for alcohol use disorder (AUD) and advanced liver disease, addressing the stigma that often prevents patients from seeking help. The study will evaluate existing and novel therapies, including behavioral interventions and medications, to enhance patient outcomes and reduce mortality rates. By fostering collaboration between AUD and liver disease specialists, the research seeks to create a comprehensive treatment approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with severe alcohol-associated hepatitis or decompensated alcohol-associated cirrhosis.
Not a fit: Patients with mild alcohol-related liver conditions or those who do not consume alcohol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective therapies that significantly improve survival rates and quality of life for patients with alcohol-associated liver disease.
How similar studies have performed: Previous studies have shown promising results with integrated treatment approaches for alcohol use and liver disease, indicating potential for success in this research.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Mitchell, Mack Clarence — Ut Southwestern Medical Center
- Study coordinator: Mitchell, Mack Clarence
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.